{"DataElement":{"publicId":"2902443","version":"1","preferredName":"Hodgkin's Lymphoma Modified Ann Arbor Staging System Stage","preferredDefinition":"Classification of severity/extent of Hodgkins Disease (HD) lymphoma based on the modified Ann Arbor or Cotswold staging system, which categorizes HD into four stages based on anatomic lymph node group involvement.","longName":"HD_MOD_ANNARB_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2902422","version":"1","preferredName":"Hodgkin's Lymphoma Stage","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of Reed-Sternberg cells.  There are two distinct subtypes: nodular lymphocyte predominant Hodgkin's lymphoma and classical Hodgkin's lymphoma.  Hodgkin's lymphoma has a bimodal age distribution, and involves primarily lymph nodes.  Current therapy for Hodgkin's lymphoma has resulted in an excellent outcome and cure for the majority of patients. -- 2003_The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"HD_LYMPH_STG","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2676478","version":"1","preferredName":"Hodgkin's Lymphoma","preferredDefinition":"A lymphoma, previously known as Hodgkin's disease, characterized by the presence of Reed-Sternberg cells.  There are two distinct subtypes: nodular lymphocyte predominant Hodgkin's lymphoma and classical Hodgkin's lymphoma.  Hodgkin's lymphoma has a bimodal age distribution, and involves primarily lymph nodes.  Current therapy for Hodgkin's lymphoma has resulted in an excellent outcome and cure for the majority of patients. -- 2003","longName":"C9357","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hodgkin Lymphoma","conceptCode":"C9357","definition":"A lymphoma characterized by the presence of relatively few malignant cells called Reed-Sternberg cells and mononuclear Hodgkin cells that are admixed with nonneoplastic inflammatory cells. The malignant cells have a distinctive immunophenotype; they are positive for CD30 and CD15 and negative for CD3, CD20, and CD45.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"393A2F0A-921A-1C8E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-09-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-09-03","modifiedBy":"ONEDATA","dateModified":"2007-09-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2224086","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63F1A4F-0A96-5494-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-03","endDate":null,"createdBy":"UMLLOADER_CAMOD","dateCreated":"2005-05-03","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA0497D-42DD-CD1B-E040-BB89AD434375","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2902432","version":"1","preferredName":"Modified Ann Arbor Lymphoma Staging System Stage","preferredDefinition":"Changed or altered in form or character._The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"MOD_ANNARB_STG","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"5","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Hodgkin's Disease has spread to one or more organs or sites outside of the lymphatic system, with/without associated lymph node involvement","ValueMeaning":{"publicId":"2902433","version":"1","preferredName":"Hodgkin's Disease has spread to one or more organs or sites outside of the lymphatic system, with/without associated lymph node involvement","longName":"2902433","preferredDefinition":"Hodgkin's Disease has spread to one or more organs or sites outside of the lymphatic system, with/without associated lymph node involvement","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-1926-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-193F-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"III 2","valueDescription":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with involved nodes of the aorta, iliac artery, or mesenteric artery","ValueMeaning":{"publicId":"2902434","version":"1","preferredName":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with involved nodes of the aorta, iliac artery, or mesenteric artery","longName":"2902434","preferredDefinition":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with involved nodes of the aorta, iliac artery, or mesenteric artery","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-1949-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-1962-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"III 1","valueDescription":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with/without involved nodes of the spleen, hilum, abdomen, or liver","ValueMeaning":{"publicId":"2902435","version":"1","preferredName":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with/without involved nodes of the spleen, hilum, abdomen, or liver","longName":"2902435","preferredDefinition":"Hodgkin's Disease involves lymph nodes on both sides of the diaphragm with/without involved nodes of the spleen, hilum, abdomen, or liver","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-196C-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-1985-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"IIIE","valueDescription":"Hodgkin's Disease has extended to an organ or site next to the lymph node(s) and/or spleen","ValueMeaning":{"publicId":"2902436","version":"1","preferredName":"Hodgkin's Disease has extended to an organ or site next to the lymph node(s) and/or spleen","longName":"2902436","preferredDefinition":"Hodgkin's Disease has extended to an organ or site next to the lymph node(s) and/or spleen","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-198F-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-19A8-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"III","valueDescription":"Hodgkin's Disease involves lymph node groups on both sides of the diaphragm","ValueMeaning":{"publicId":"2902437","version":"1","preferredName":"Hodgkin's Disease involves lymph node groups on both sides of the diaphragm","longName":"2902437","preferredDefinition":"Hodgkin's Disease involves lymph node groups on both sides of the diaphragm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-19B2-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-19CB-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"IIE","valueDescription":"Hodgkin's Disease involves one or more lymph node groups on the same side of the diaphragm and there is localized involvement of the node(s) to one organ or site on the same side of the diaphragm","ValueMeaning":{"publicId":"2902438","version":"1","preferredName":"Hodgkin's Disease involves one or more lymph node groups on the same side of the diaphragm and there is localized involvement of the node(s) to one organ or site on the same side of the diaphragm","longName":"2902438","preferredDefinition":"Hodgkin's Disease involves one or more lymph node groups on the same side of the diaphragm and there is localized involvement of the node(s) to one organ or site on the same side of the diaphragm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-19D5-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-19EE-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"II","valueDescription":"Hodgkin's Disease involves two or more lymph node groups on the same side of the diaphragm","ValueMeaning":{"publicId":"2902439","version":"1","preferredName":"Hodgkin's Disease involves two or more lymph node groups on the same side of the diaphragm","longName":"2902439","preferredDefinition":"Hodgkin's Disease involves two or more lymph node groups on the same side of the diaphragm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-19F8-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-1A11-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"IE","valueDescription":"Hodgkin's Disease extends locally to involve a single adjacent site","ValueMeaning":{"publicId":"2902440","version":"1","preferredName":"Hodgkin's Disease extends locally to involve a single adjacent site","longName":"2902440","preferredDefinition":"Hodgkin's Disease extends locally to involve a single adjacent site","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-1A1B-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-1A34-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"I","valueDescription":"Hodgkin's Disease involves one lymph node group or structure","ValueMeaning":{"publicId":"2902441","version":"1","preferredName":"Hodgkin's Disease involves one lymph node group or structure","longName":"2902441","preferredDefinition":"Hodgkin's Disease involves one lymph node group or structure","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-1A3E-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CA078B2-1A57-BA97-E040-BB89AD436981","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"ONEDATA","dateModified":"2009-06-18","deletedIndicator":"No"},{"value":"IIIE and IIIS","valueDescription":"Ann Arbor Stage IIIE and IIIS","ValueMeaning":{"publicId":"6296036","version":"1","preferredName":"Ann Arbor Stage IIIE and IIIS","longName":"6296036","preferredDefinition":"An Ann Arbor classification lymphoma stage term that refers to extralymphatic organ or site involvement plus involvement of lymph nodes on both sides of the diaphragm or involvement of lymph nodes on both sides of the diaphragm plus involvement of the spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Stage IIIE and IIIS","conceptCode":"C150551","definition":"An Ann Arbor classification lymphoma stage term that refers to extralymphatic organ or site involvement plus involvement of lymph nodes on both sides of the diaphragm or involvement of lymph nodes on both sides of the diaphragm plus involvement of the spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C7D1922-DA78-7805-E053-F662850A88D9","latestVersionIndicator":"Yes","beginDate":"2018-05-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-18","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD986F2E-3CA5-3EA6-E053-4EBD850A8D85","beginDate":"2021-03-15","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"},{"value":"IIIS","valueDescription":"Ann Arbor Stage IIIS","ValueMeaning":{"publicId":"6296061","version":"1","preferredName":"Ann Arbor Stage IIIS","longName":"6296061","preferredDefinition":"An Ann Arbor classification lymphoma stage term that refers to the involvement of lymph nodes on both sides of the diaphragm plus involvement of the spleen.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ann Arbor Stage IIIS","conceptCode":"C150550","definition":"An Ann Arbor classification lymphoma stage term that refers to the involvement of lymph nodes on both sides of the diaphragm plus involvement of the spleen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C7DB211-680F-4D2A-E053-F662850A65EA","latestVersionIndicator":"Yes","beginDate":"2018-05-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-18","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BD986F2E-3CB9-3EA6-E053-4EBD850A8D85","beginDate":"2021-03-15","endDate":null,"createdBy":"MAESKEB","dateCreated":"2021-03-15","modifiedBy":"ONEDATA","dateModified":"2021-03-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3691017","version":"1","preferredName":"Change Ann Arbor Lymphoma Staging System Stage","preferredDefinition":"The act of alteration or modification; changed or altered in form or character.:The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C25446:C54179:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Ann Arbor Lymphoma Staging System","conceptCode":"C54179","definition":"The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group or location defines stage I. Disease limited to one side of the diaphragm, (the muscle separating the chest from the abdomen), defines stage II. Stage III patients have disease on both sides of the diaphragm and stage IV patients once again have disseminated disease. Consideration of involvement of the liver, spleen, and bone marrow are also considered in this system. Finally, the stage is subdivided into categories of A and B depending on the presence of symptoms of itching, weight loss, fever, and night sweats. Those having symptoms receive the designation \"B\" and have a worse prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D6A8CB99-F295-B6FF-E040-BB89AD433C39","latestVersionIndicator":"Yes","beginDate":"2013-02-26","endDate":null,"createdBy":"CURTIST","dateCreated":"2013-02-26","modifiedBy":"ONEDATA","dateModified":"2013-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CA078B2-1913-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"TSESU","dateModified":"2021-03-16","changeDescription":"02/26/2013 - tc - Removed retired concept C25573 and replaced with C25446.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461038","version":"1","longName":"Lymphoma (Includes Hodgkins)","context":"NCIP"},{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461152","version":"1","longName":"Hematologic Staging","context":"NCIP"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000689","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"LYM_RSORRES","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Modified Ann Arbor Stage","type":"Preferred Question Text","description":"Modified Ann Arbor Stage","url":null,"context":"NCI Standards"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"6CA078B2-1A61-BA97-E040-BB89AD436981","latestVersionIndicator":"Yes","beginDate":"2009-06-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-06-18","modifiedBy":"KUMMEROA","dateModified":"2023-08-31","changeDescription":"Curated as part of NCI CRF Standards staging module","administrativeNotes":"2023.8/.30 Alt VMs added per ticket request CADSR0002801. ak","unresolvedIssues":null,"deletedIndicator":"No"}}